Michael J. Glennon
Known title: DirectorCIK: 0001665434
Michael J. Glennon's purchase track record
Michael J. Glennon has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/5/2022 | PAVM | $161K | -29.4% | -32.9% | +6.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| PAVM | ▲ Buy | Grant | 13,930 | $0 | 4/2/2026 | View on chart |
| PAVM | ▲ Buy | Grant | 150,000 | $0 | 9/30/2025 | View on chart |
| PAVM | ▲ Buy | Grant | 65,000 | — | 2/22/2024 | View on chart |
| PAVM | ▲ Buy | Open Market | 100,000 | $62K | 12/7/2022 | View on chart |
| PAVM | ▲ Buy | Open Market | 88,000 | $56K | 12/6/2022 | View on chart |
| PAVM | ▲ Buy | Open Market | 62,000 | $43K | 12/5/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
PAVmed Included in List of Moving Health Care Stocks
PAVmed was featured in a Benzinga article highlighting health care stocks with notable intraday movement on Thursday. The stock is currently trading near its 52-week low, with technical indicators showing oversold conditions and a recent breakdown below support levels. This inclusion reflects current market attention to the stock's price action rather than a specific corporate announcement.
PAVmed Included in List of Moving Health Care Stocks. PAVmed was featured in a Benzinga article highlighting health care stocks with notable intraday movement on Thursday. The stock is currently trading near its 52-week low, with technical indicators showing oversold conditions and a recent breakdown below support levels. This inclusion reflects current market attention to the stock's price action rather than a specific corporate announcement.